OpGen

Microbial whole genome comparative analysis

OpGen is commercializing a novel single molecule DNA analysis technology, "Optical Mapping", for rapid identification and analysis of microorganisms. The system provides detailed genetic information, with no requirement for prior sequence data, PCR, cloning, or probes, and allows high-resolution comparison of entire microbial genomes to detect the rearrangements responsible for most microbial genetic variation.

OpGen, headquartered in Madison Wisconsin, is developing instrumentation and disposable lab-cards for automated microbial ID and antibiotic resistance testing in the clinical microbiology market, for forensic microbiology and plans to develop novel molecular diagnostic products.

In-Q-Tel initially invested in OpGen in September 2007. For more information about OpGen, please visit www.opgen.com.

Technology Focus Areas

  • Physical and Biological Technologies
  • Security
  • Software and Infrastructure

More Company Information

OpGen Company Card

OpGen Press Release